Back to Companies
Atea Pharmaceuticals, Inc.
AVIRNasdaqCIK: 0001593899
Over the 17 most recent insider filings, Atea Pharmaceuticals, Inc. (AVIR) has seen activity from 14 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $50.9K bought versus $0 sold, a net purchase of $50.9K. Sommadossi Jean-Pierre is the most active by dollar volume, and the single largest transaction was $1.2M by Sommadossi Jean-Pierre. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$6.2M
Purchases
$50.9K
Sales
$0
Unique Insiders
14
Recent Insider Trades
17 loaded
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | KIRSCH ARTHUR S | Insider | Award | $164.4K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | Polsky Bruce | Insider | Exercise | $164.4K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | DUNCAN BARBARA GAYLE | Insider | Exercise | $164.4K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | Adams Jerome M. | Insider | Exercise | $164.4K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Insider | Exercise | $164.4K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | Murphy Polly A. | Insider | Exercise | $164.4K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | Berman Howard | Insider | Award | $164.4K |
| Jun 23 | AVIR Atea Pharmaceuticals, Inc. | Lucidi Bruno | Insider | Exercise | $164.4K |
| May 21 | AVIR Atea Pharmaceuticals, Inc. | Murphy Polly A. | Insider | Buy | $25.4K |
| May 20 | AVIR Atea Pharmaceuticals, Inc. | Murphy Polly A. | Insider | Buy | $25.4K |
| Mar 13 | AVIR Atea Pharmaceuticals, Inc. | Corcoran Andrea | Insider | Exercise | $148.8K |
| Feb 3 | AVIR Atea Pharmaceuticals, Inc. | Corcoran Andrea | Insider | Exercise | $831.5K |
| Feb 3 | AVIR Atea Pharmaceuticals, Inc. | Horga Maria Arantxa | Insider | Exercise | $803.8K |
| Feb 3 | AVIR Atea Pharmaceuticals, Inc. | Sommadossi Jean-Pierre | Insider | Exercise | $1.2M |
| Feb 3 | AVIR Atea Pharmaceuticals, Inc. | Foster Wayne | Insider | Exercise | $509.4K |
| Feb 3 | AVIR Atea Pharmaceuticals, Inc. | Hammond Janet MJ | Insider | Exercise | $810.4K |
| Feb 3 | AVIR Atea Pharmaceuticals, Inc. | Vavricka John | Insider | Exercise | $555.8K |
17 filings